Natural Product Research
265
fr. 1, which was chromatographed over Sephadex LH-20 [H2O–MeOH (90% MeOH, 100%
MeOH)] to yield frs. 2–4. Chromatography of fr. 2 (5.8 g) over silica gel [CHCl3–MeOH–H2O
(14:2:0.1, 10:2:0.1, 8:2:0.2, 7:3:0.5, 6:4:1, 0:1:0)] furnished frs. 2-1–2-4. Fraction 2-2 (97 mg)
was chromatographed over Chromatorex ODS [H2O–MeOH (30% MeOH, 40% MeOH, 50%
MeOH, 60% MeOH, 70% MeOH, 80% MeOH, 90% MeOH, 100% MeOH)] to yield frs. 2-2-1–
2-2-4. Fractions 2-2-2 (14 mg) and 2-2-3 (11 mg) were each subjected to HPLC (30% MeOH) to
afford 5 (6 mg) from fr. 2-2-2 and 2 (4 mg) from fr. 2-2-3. Chromatography of fr. 2-3 (1.4 g) over
Chromatorex ODS [H2O–MeOH (20% MeOH, 30% MeOH, 40% MeOH, 50% MeOH, 60%
MeOH, 70% MeOH, 80% MeOH, 90% MeOH, 100% MeOH)] furnished frs. 2-3-1–2-3-8.
Fractions 2-3-2 (17 mg), 2-3-4 (120 mg), 2-3-5 (34 mg) and 2-3-7 (18 mg) were each subjected to
HPLC (fr. 2-3-2, 15% MeOH; frs. 2-3-4, 2-3-5, and 2-3-7, 65% MeOH) to yield 1 (7 mg) from fr.
2.3.2, 9 (10 mg) from fr. 2-3-4, 8 (3 mg) from fr. 2-3-5 and 7 (6 mg) from fr. 2-3-7. Fraction 3
(3.7 g) was chromatographed over silica gel [CHCl3–MeOH–H2O (10:2:0.1, 8:2:0.2, 7:3:0.5,
6:4:1, 0:1:0)] to yield frs. 3-1–3-7. Fraction 3-2 (253 mg) was subjected to Chromatorex ODS
[H2O–MeOH (10% MeOH, 20% MeOH, 30% MeOH, 40% MeOH, 50% MeOH, 60% MeOH,
70% MeOH, 80% MeOH, 100% MeOH)] to yield frs. 3-2-1–3-2-4. Fractions 3-4 (102 mg), 3-6
(143 mg), 3-2-2 (29 mg) and 3-2-3 (30 mg) were each subjected to HPLC (frs. 3-4 and 3-6, 30%
MeOH; frs. 3-2-2 and 3-2-3, 20% MeOH) to afford 4 (7 mg) from fr. 3-4, 3 (21 mg) from fr. 3-6,
5 (6 mg) from fr. 3-2-2 and 6 (18 mg) from fr. 3-2-3.
1
25
1: Amorphous powder. ½aꢀD –42.68 (c ¼ 0.8, MeOH). H NMR (pyridine-d5, 500 MHz) d:
5.15 (1H, d, J ¼ 7.5 Hz, Glc0-1), 4.87 (1H, dd, J ¼ 1.5 and 11.5 Hz, Glc-6a), 4.76 (1H, d,
J ¼ 8.0 Hz, Glc-1), 4.54 (1H, dd, J ¼ 1.5 and 12.0 Hz, Glc0-6a), 4.39 (1H, dd, J ¼ 4.5 and
12.0 Hz, Glc0-6b), 4.36 (1H, dd, J ¼ 6.5 and 11.5 Hz, Glc-6b), 4.27* (Glc0-4), 4.26* (Glc0-3),
4.21 (1H, dd, J ¼ 8.5 and 8.5 Hz, Glc-3), 4.16 (1H, dd, J ¼ 8.5 and 8.5 Hz, Glc-4), 4.11 (1H, m,
Glc-5), 4.08* (Agl-1a), 4.06* (Glc0-2), 4.00 (1H, dd, J ¼ 8.0 and 8.5 Hz, Glc-2), 3.99 (1H, dd,
J ¼ 6.5 and 9.5 Hz, Agl-1b), 3.95 (1H, m, Glc0-5), 1.72 (1H, m, Agl-2), 1.51 (1H, m, Agl-3a),
1.11 (1H, m, Agl-3b), 0.94 (3H, d, J ¼ 7.0 Hz, Agl-5), 0.80 (3H, t, J ¼ 7.5 Hz, Agl-4). Asterisk
13
(*) indicates overlapping signals. C NMR (pyridine-d5, 125 MHz) d: 105.5 (Glc0-1), 104.9
(Glc-1), 78.5 (Glc-3), 78.5 (Glc0-3), 78.5 (Glc0-5), 77.3 (Glc-5), 75.3 (Glc0-2), 75.1 (Glc-2), 75.0
(Agl-1), 71.8 (Glc-4), 71.7 (Glc0-4), 70.2 (Glc-6), 62.8 (Glc0-6), 35.4 (Agl-2), 26.4 (Agl-3), 16.8
(Agl-5), 11.4 (Agl-4). Positive FAB-MS m/z: 435 [M þ Na]þ. HR-positive FAB-MS m/z:
435.1836 (calcd for C17H32O11Na: 435.1843).
1
25
8: Amorphouspowder. ½aꢀD –29.38(c ¼ 0.4,MeOH). HNMR(pyridine-d5, 500 MHz)d: 5.54
[1H, d, J ¼ 7.5 Hz, terminal glucosyl group (Glc0)-1], 5.19 [1H, d, J ¼ 7.5 Hz, xylosyl group (Xyl)-
1], 5.15 [1H, J ¼ 8.0 Hz, inner glucosyl group (Glc)-1], 4.99 [1H, ddd, J ¼ 4.5, 7.5 and 7.5 Hz,
aglycone moiety (Agl)-16], 4.90 [1H, d, J ¼ 8.0 Hz, galactosyl group (Gal)], 4.64 (1H, dd, J ¼ 8.5
and 11.0Hz, Gal-6a), 4.61 (1H, d, J ¼ 3.5 Hz, Gal-4), 4.52 (1H, dd, J ¼ 1.5 and 10.5Hz, Glc0-6a),
4.49 (1H, dd, J ¼ 1.5 and 10.0Hz, Glc-6a), 4.41 (1H, dd, J ¼ 7.5 and 9.5 Hz, Gal-2), 4.37* (Glc0-
6b), 4.34 (1H, dd, J ¼ 8.0 and 8.5 Hz, Glc-2), 4.23* (Gal-6b), 4.23* (Xyl-5a), 4.18* (Gal-3), 4.18*
(Xyl-3), 4.17* (Glc0-4), 4.12* (Xyl-4), 4.11 (1H, dd, J ¼ 8.5 and 8.5 Hz, Glc-3), 4.09* (Glc0-3), 4.07
(1H, dd, J ¼ 7.5 and 8.5 Hz, Glc0-2), 4.05* (Gal-5), 4.03* (Glc-6b), 3.95(1H, ddJ ¼ 8.0 and 8.5 Hz,
Xyl-2), 3.94* (Agl-3), 3.93* (Glc0-5), 3.85* (Glc-5), 3.78 (1H, dd, J ¼ 8.5 and 8.5 Hz, Glc-4), 3.68
(1H, dd, J ¼ 10.5 and 10.5Hz, Xyl-5b), 2.70 (1H, q, 7.5), 2.17 (1H, ddd, J ¼ 6.5, 7.5 and 14.0Hz,
Agl-15a), 2.06 (1H, m, Agl-2a), 1.84 (1H, br d, J ¼ 7.5 Hz, Agl-17), 1.81* (Agl-4a), 1.65* (Agl-
12a), 1.61* (Agl-2b), 1.50* (Agl-7a), 1.48* (Agl-1a), 1.40* (Agl-4b), 1.39* (Agl-15b), 1.37* (Agl-
11a), 1.31 (3H, d, J ¼ 7.5 Hz, Agl-21), 1.27* (Agl-8), 1.14* (Agl-6a), 1.11* (Agl-11b), 1.09* (Agl-
6b),1.00(1H,m, Agl-12b),0.92*(Agl-14), 0.90*(Agl-5), 0.81*(Agl-7b), 0.79*(Agl-1b), 0.70(3H,
s, Agl-18), 0.62(3H, s,Agl-19), 0.51(1H,ddd,J ¼ 2.5,8.5and8.5 Hz, Agl-9). Asterisk(*)indicates
overlappingsignals.13CNMR(pyridine-d5, 125MHz)d: 181.1 (Agl-22), 105.1(Glc-1), 104.9(Xyl-
1), 104.8 (Glc0-1), 102.4 (Gal-1), 86.8 (Glc-3), 82.7 (Agl-16), 81.3 (Glc-2), 79.9 (Gal-4), 78.7 (Agl-